Recombinant human antithrombin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human antithrombin, covering 2012-10-16 to 2012-10-16. Get the full timeline:
Most recent: Clinical Trial Update: Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations. [Phase 3]